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Abstract
Objectives: To assess the safety and efficacy in routine clinical practice of balloon 
dilatation procedures in the treatment of paediatric airway stenosis.
Design: Observational data collection in prospective online research database.
Setting: Acute NHS Trusts with ENT department undertaking complex paediatric air-
way work.
Participants: Children (<18) undergoing balloon dilatation treatment for airway stenosis.
Main outcome measures: Airway diameter, complications, hospital resource usage.
Results: Fifty-nine patients had 133 balloon procedures during 128 visits to 10 hos-
pitals. Sixty-nine (52%) of balloon procedures were conducted with a tracheostomy. 
Intra-operative Cotton-Myer grade decreased in 43 (57%). The mean pre-balloon sub-
glottic diameter was 4.2 [95% CI: 3.8 to 4.5] mm, and its rate of increase was 0.8 [0.5 
to 1.2] mm per year modelled on 30 patients’ long-term data. As the primary treat-
ment of stenosis, the procedural success rate of balloon dilatation (n = 52) was 65% 
(22% with tracheostomy, 88% without tracheostomy), and 71% as an adjunct to open 
reconstructive surgery (n = 7). In the 64 hospital visits where a balloon procedure 
was conducted with a tracheostomy in place, only one in-hospital complication (lower 
respiratory tract infection) occurred. For those without a tracheostomy in place, in-
hospital complications occurred in seven of 64 balloon hospital visits, all related to on-
going or worsening stenosis. Six out-of-hospital complications were deemed related to 
ongoing or worsening stenosis following the procedure, and two complications were a 
combination of lower respiratory infection and ongoing or worsening stenosis.
Conclusions: Balloon dilation increases the size of the airway intraoperatively and 
is associated with long-term increase in airway diameter. Safety outcomes mostly 
relate to ongoing or worsening stenosis and are more common in patients without a 
tracheostomy.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction 
in any medium, provided the original work is properly cited and is not used for commercial purposes. 
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1  | INTRODUC TION
Stenosis (narrowing) of the airway encompasses a range of potentially 
life-threatening conditions that may be congenital or caused by pro-
longed or repeated airway intubation. Children with airway stenosis 
often experience difficulties with breathing, speaking or eating.1 Such 
symptoms may require further intubation, leading to a cyclical problem. 
Surgical interventions for airway stenosis include cricoid split proce-
dures, reconstructive laryngotracheal procedures and more commonly, 
tracheostomy. Endoscopic balloons offer a potential alternative or ad-
junct to open surgery.2 In 2012, the National Institute for Health and 
Care Excellence (NICE) published Interventional Procedures Guidance 
which identified that safety and efficacy evidence for endoscopic bal-
loon dilatation for subglottic or tracheal stenosis was lacking in quantity 
and quality.3 The guidance recommended that clinicians wishing to con-
duct the procedure should do so under special arrangements for clinical 
governance, audit and consent, including national data collection.
In response to this NICE guidance, the Airway Intervention 
Registry (AIR) was developed, enabling UK data collection for ENT/
respiratory procedures conducted on children.4 This study reports 
results from the AIR, to determine whether balloon dilatation pro-
cedures in the treatment of paediatric airway stenosis are effective 
and safe, in a National Health Service (NHS) setting.
2  | MATERIAL S AND METHODS
2.1 | Ethical considerations
Favourable opinion was received from the Newcastle & North 
Tyneside 1 Research Ethics Committee on 29 December 2014 (REC 
reference: 14/NEC/1200).
2.2 | Data source
The AIR is hosted by The Newcastle upon Tyne Hospitals NHS 
Foundation Trust in collaboration with the British Association for 
Paediatric Otorhinolaryngology and NICE. Data submission commenced 
on 27 March 2015. This study was adopted onto the NIHR Clinical 
Research Network portfolio on 18 November 2016 (CPMS 32800).
The AIR records the following: clinical history, patient questionnaires, 
medical assessments, procedural details, post-procedure, discharge and 
hospital resource usage information (Supplementary Material 1). Data 
were extracted from the AIR for analysis on 3 October 2019.
2.3 | Study population
2.3.1 | Inclusion criteria
Patients <18 years old with airway stenosis treated by balloon dilata-
tion within an acute NHS hospital.
2.3.2 | Exclusion criteria
Procedures conducted for indications other than airway stenosis 
and records with no balloon dilatation procedure data.
2.4 | Data cleaning
Balloon procedures were numbered consecutively for each patient 
based on the hospital procedure date. Interim analyses and data 
quality checks were conducted bi-monthly.
2.5 | Data coverage
Registry coverage was estimated by comparing the number of in-
patient/day-case balloon procedures reported by NHS hospitals 
in England with the total number of airway balloon procedures re-
corded in the Hospital Episode Statistics (HES) Admitted Patient 
Care (APC) data set for the data collection period.5 HES data (be-
tween 1 April 2015 and 31 March 2019 provisional data set) were 
interrogated using the clinical codes described in Supplementary 
Material 2. Pseudonymised data from the HES and the Office of 
National Statistics (ONS) mortality data set were supplied under 
DARS agreement DAR-NIC-17011-Z1B4J.
2.6 | In-hospital outcome measures
Efficacy outcome measures were as follows: intra-operative 
change in airway diameter (millimetres) and Cotton-Myer grade 
directly before and after the balloon dilatation intervention. 
Cotton-Myer grade was calculated using the measured airway 
Keypoints
• A total of 133 balloon procedures conducted during 128 
hospital visits in 59 paediatric patients with airway ste-
nosis were recorded in the Airway Intervention Registry.
• 88% of visits were for the sole and primary treatment 
for stenosis, 50% with a tracheostomy in place.
• Balloon dilatation was associated with increase in airway 
diameter over time, but this was not compared with in-
creases due to natural growth.
• Procedural success (defined as not requiring tracheos-
tomy and avoiding open airway surgery) was achieved 
in 88% of patients without tracheostomy undergoing 
primary treatment of stenosis.
• In-hospital complications occurred in 8/133 balloon dil-
atation procedures (6%). However, there is no long-term 
adverse safety signal.
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diameter compared with an age-related healthy cricoid anter-
oposterior diameter.6 In the absence of a measured airway diam-
eter, Cotton-Myer grade was estimated by the treating clinician. 
Safety outcome measures included in-hospital complications 
and in-hospital death. All reported complications were clinically 
reviewed and aggregated into an in-hospital complication rate. 
Secondary outcome measures were hospital resource usage, dis-
charge to planned location and length of stay.
2.7 | Longer-term outcome measures
The AIR and HES were pseudonymously linked on treating hospital, 
patient gender, age, procedure, admission and discharge dates to 
create longitudinal records for registry patients. Each patient was 
followed from the date of their earliest balloon dilatation procedure 
until either the 31 March 2019 (if matched to HES), the latest date in 
the registry for the patient (if unmatched to HES), or date of death, 
if sooner.
Outcomes from the AIR were changed in airway diameter over 
time, and all reported post-procedural complications. Secondary 
outcome measures included hospital resource usage and subse-
quent airway intervention. Outcomes from HES were subsequent 
hospital admissions, further respiratory surgical intervention 
(Supplementary Material 3) and in-hospital deaths. For those pa-
tients successfully matched to HES, all-cause mortality was ex-
tracted from ONS.
Overall procedural success at the end of the study was defined 
as avoidance of surgical intervention (eg laryngotracheal reconstruc-
tion or tracheostomy insertion) for those with no tracheostomy 
present at the time of the index balloon procedure and maintained 
decannulation for those with tracheostomy in place.7,8 Subgroup 
analysis of overall procedural success was conducted for patients 
undergoing primary treatment of stenosis and those undergoing ad-
junctive treatment post-reconstructive surgery.
2.8 | Statistical analysis
All scripts for applying eligibility criteria, data cleaning, processing 
and statistical analysis were written in the statistical programming 
language R.9
Patient characteristics, clinical history and complications 
were summarised using descriptive statistics. Repeated-measures 
models (taking into account the random effect of some patients 
having multiple balloon procedures over time) were used to test 
for intra-operative changes in airway diameter with confidence 
intervals and significance-level derived using a parametric boot-
strap hypothesis test with a generalised likelihood ratio test 
statistic.10 Cotton-Myer grades before and after the balloon dila-
tation procedure (in-hospital) were compared using Fisher's exact 
tests.11
3  | RESULTS
3.1 | Cohort for analysis
A total of 65 patients were entered into the AIR database; five pa-
tients did not have any recorded information regarding the balloon 
dilatation intervention, and one procedure was conducted for indi-
cations other than airway stenosis (Supplementary Material 4). The 
remaining 59 patients had a total of 133 balloon procedures during 
128 separate hospital visits, at 10 treating centres.
3.2 | Data coverage
A total of 247 hospital admissions (212 balloon dilatations of sub-
glottic stenosis, 35 balloon dilatations of tracheal stenosis) in 170 
paediatric patients were identified in the HES APC data set using the 
recommended clinical coding advised in NICE IPG425. This would 
give an estimated registry coverage of 51% (125/247). More gener-
ally, 2370 hospital admissions from 1164 paediatric patients were 
identified using generic respiratory procedure codes (“E” chapter 
in OPCS) supplemented by a dilatation of organ “Y40” OPCS code 
(Supplementary Material 4), and we cannot exclude the possibility 
that some of these were eligible procedures not coded using NICE 
recommendations.
3.3 | Patient characteristics
Characteristics of the 59 eligible patients are summarised in 
Table 1. Fifty patients (85%) had a history of prolonged intubation 
(admitted to intensive care unit [ICU] > 24 hour), and 16 (27%) 
had a history of difficult/traumatic intubation. No Voice Handicap 
Index12 and nine general quality of life questionnaires were en-
tered into the AIR.
3.4 | Procedures
Characteristics of the 133 registry procedures are summarised in 
Table 2; 31 patients had a single balloon dilatation procedure, 13 had 
two, five had three, five had four, and five patients had five or more 
(maximum of nine balloon dilatation procedures in one patient). A 
total of 69 (52%) balloon procedures were conducted with a tra-
cheostomy in place, 50 (38%) alongside cold steel or laser incisions, 
79 (59%) in combination with steroid treatment, 35 (26%) alongside 
concomitant procedures (such as cyst, granulation or scar tissue re-
moval, web division, stent insertion, endoscopic cricoid split, endo-
scopic posterior cartilage graft, laryngotracheal reconstruction with 
cartilage, recurrent respiratory papillomatosis debridement, suture 
lateralisation of vocal cord, triamcinolone injection) and 15 (11%) as 
adjunctive/secondary treatment after open reconstruction surgery.
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3.5 | In-hospital outcomes
Seventy paired measurements of airway diameter (ie before and 
after a balloon procedure) were recorded from 39 patients (Figure 1). 
The starting airway diameter, stenosis type (oedema, soft and hard), 
Cotton-Myer grade (pre-balloon) and procedure number were not 
associated with intra-operative change in subglottic airway di-
ameter (Supplementary Material 5-8). Of the 76 procedures with 
Cotton-Myer grade reported both before and after the procedure, 
a decrease in Cotton-Myer grade (ie immediate reduction in airway 
stenosis) was documented in 43 (57%), and the Cotton-Myer grade 
was unchanged in 33 (43%).
The anticipated and actual discharge location was recorded in 
127 balloon visits, with 94% going to their expected discharge loca-
tion; 4 procedures with no tracheostomy resulted in an unplanned 
ICU visit with intubation, three procedures with no tracheostomy 
TA B L E  1   Patient characteristics for all eligible patients
 
All eligible 
patients (n = 59)
Male 36 (61%)
Age, y
Neonates (<1 y) 21 (36%)
Toddlers (1-2 y) 7 (12%)
Children (3-11 y) 28 (47%)
Adolescents (12-18 y) 3 (5%)
Ethnicity
Caucasian 45 (76%)
Asian 7 (12%)
Black 5 (9%)
Other 2 (3%)
Gestation at birth (wk)
<25 12 (20%)
25-29 16 (27%)
30-36 8 (14%)
37+ 23 (39%)
No. of previous intubations
0 1 (2%)
1-2 16 (27%)
3-5 15 (25%)
5+ 15 (25%)
Comorbiditiesa
Chronic lung disease 29 (49%)
Reflux 17 (29%)
Recurrent lower respiratory infection 5 (9%)
Other 26 (45%)
None 10 (17%)
Weight, kgb,c median (Q1,Q3) [range] 11.2 (7.5,15.5) 
[3.0-57.0]
Medications at time of assessmenta,b
Anti-reflux 43 (34%)
Antibiotics (prophylactic) 26 (20%)
Other 28 (22%)
None 49 (38%)
aMultiple choices permitted. 
bRecorded per hospital visit (n = 128). 
cInfluence on balloon size. 
TA B L E  2   Characteristics of balloon dilatation procedures
 
All balloon 
procedures (n = 133)
Stenosis location
Glottis 27 (20%)
Subglottis 105 (79%)
Trachea 1 (1%)
Stenosis type
Oedema and granulations only 17 (13%)
Soft or immature scar tissue 66 (50%)
Hard, firm or mature scar tissue 49 (37%)
Laryngeal web 1 (1%)
Cause of stenosisa
Intubation or ICU care 100 (75%)
Prematurity 54 (41%)
Congenital 20 (15%)
Infection 5 (4%)
Secondary to tracheostomy 1 (1%)
Other 19 (14%)
Airway diameter, mm median (Q1,Q3) [range]
Glottis (n = 9) 4.2 (4.0,4.8) [2.0-4.8]
Subglottis (n = 81) 4.2 (3.5,5.4) [1.0-8.0]
Upper trachea (n = 1) 6.0 (6.0,6.0) [6.0-6.0]
Cotton-Myer grade
1 39 (40%)
2 32 (33%)
3 26 (27%)
4 0 (0.0%)
Balloon catheter diameter (n = 126), mm 
median (Q1,Q3) [range]
7 (7,8) [4-10]
Balloon catheter length (n = 72), mm 
Median (Q1,Q3) [range]
40 (24,40) [10-55]
Balloon pressure (n = 101), median 
(Q1,Q3) [range]
10 (7,12) [3-16]
No. of inflations (n = 112), median (Q1,Q3) 
[range]
2 (2,2) [1-5]
Average duration of individual dilatations 
(n = 100), s median (Q1,Q3) [range]
60 (60,60) [2-120]
Topical Mitomycin C 2 (1%)
Length of stay, days (n = 90)b median 
(Q1,Q3) [range]
0.5 (0,1) [0-19]
aMultiple choices permitted. 
bCalculated per hospital visit (n = 128). 
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required an unplanned high-dependency unit (HDU) visit without in-
tubation and one patient with a tracheostomy was admitted to ward 
(rather than anticipated HDU).
In-hospital complications were reported in 11 hospital visits 
where a balloon dilatation procedure was conducted, three of which 
were excluded following clinical review as they were not considered 
to be a complication of the procedure (Supplementary Material 9). 
Of the 64 balloon dilatation visits with a tracheostomy in place, one 
reported an in-hospital complication (lower respiratory tract infec-
tion). Of the 64 balloon dilatation visits without a tracheostomy, 
seven reported complications (five airway obstruction, one emer-
gency tracheostomy and one staged tracheostomy with prolonged 
intubation). The increased odds of experiencing a complication with-
out a tracheostomy (versus with) were not significant, odds ratio 7.7 
[95% CI 0.9 to 64.8] and P = .06.
3.6 | Long-term outcomes
Follow-up information from the registry (after the first recorded bal-
loon admission) was available in 40 (68%) patients making 119 subse-
quent hospital visits (including 69 balloon and 50 non-balloon visits). 
A total of 45 (76%) patients from the AIR were linked to HES APC. 
Of these, 43 patients were readmitted a total of 500 times (median 
eight readmissions per patient). The total patient follow-up (across 
the two data sources) was 45,495 days, with a median follow-up 
duration of 869 days per patient (Q1:Q3 232:1152) [range 0 to 1511], 
during which 33 patients (56%) had additional balloon dilatations. No 
deaths were reported for matched patients in ONS.
A total of 91 measurements of subglottic diameter were en-
tered into the AIR for 30 patients during follow-up (20 male, me-
dian age 1.4 years, 53% with tracheostomy present, 77% with 
soft/oedema stenosis, 80% with stenosis following intubation). 
The mean pre-balloon subglottic diameter was 4.2 [95% CI: 3.8 to 
4.5] mm, and its rate of increase was 0.8 [0.5 to 1.2] mm per year 
(P < .001) (Figure 2).
Of the 59 patients having balloon dilatation procedures, 19 
out-of-hospital complications occurring in 12 patients were recorded 
in AIR. This included one death which was deemed unrelated to the 
balloon dilatation procedure by the treating clinician. Following clin-
ical review, six were deemed related to the efficacy of the balloon 
dilatation procedure, one related to safety (airway obstruction and 
lower respiratory tract infection 4 days post-balloon), one related 
to safety and efficacy (prolonged intubation due to LRTI, additional 
balloon and endoscopic anterior cricoid split 9 days post-balloon) 
and the remaining 11 reported outcomes deemed unrelated to the 
balloon procedure (and likely due to natural history of stenosis), 
Supplementary Material 10.
From HES, approximately half the cohort (29/59 patients) were 
readmitted to hospital a total of 83 times within 30 days of a balloon 
dilation procedure (Supplementary Material 11). Thirty-two of these 
readmissions within 30 days (39%) were related to airway stenosis.
F I G U R E  1   Airway diameters before 
and after balloon dilatation procedure (in-
hospital) by stenosis location and type
F I G U R E  2   Subglottic airway 
diameter over time for 30 patients. [Key: 
circles indicate individual pre-balloon 
airway diameter measurements, circles 
connected with a solid line indicate 
measurements from an individual patient, 
and the solid red line indicates the overall 
population increase in subglottic airway 
diameter over time generated from the 
linear mixed model fit taking into account 
multiple measurements in each patient]
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3.7 | Overall success
Overall procedural success rate in patients undergoing balloon dilata-
tion as the primary treatment of stenosis (n = 52) was 65% (22% in the 
presence of tracheostomy, 88% in those with no tracheostomy), and 
71% in those patients undergoing balloon dilatation as an adjunctive 
treatment subsequent to open reconstructive surgery (n = 7; Figure 3).
4  | DISCUSSION
4.1 | Synopsis of key findings
The children having balloon dilatation captured in the AIR were a 
high-risk population: 61% were born prematurely; 51% had three or 
more intubations, 49% had chronic lung disease, and 12% had ad-
junctive treatment post-laryngotracheal reconstruction.
In terms of safety, clinically verified in-hospital complications 
occurred in 8/133 balloon dilatation procedures (6%). Our study 
suggests that the rate of complication in those without a tracheos-
tomy exceeded the rate in those with, but our study was too small 
to show this conclusively. Pending further evidence, a precautionary 
approach would be to conduct balloon dilatation in large acute hos-
pitals with paediatric intensive care facilities.
In terms of efficacy, our study of 59 patients demonstrates a sig-
nificant immediate reduction in Cotton-Myer grading of stenosis in 
approximately half of patients and a longer-term increase in mean 
subglottic diameter of 0.8 mm/y. The majority of patients under-
went multiple balloon dilatations and other endoscopic procedures 
to maintain their airway, throughout the duration of this study (one 
patient having up to nine dilatations).
When considering overall procedural success, for patients un-
dergoing balloon dilatation as the primary treatment of stenosis 
the success rate was 86% in the subgroup of patients who did not 
have a tracheostomy in place at the time of the balloon. This is likely 
due to this population having softer and lower Cotton-Myer grade 
stenoses. Success rates were lower in the tracheostomy group, but 
balloon dilatation did enable 22% to be successfully decannulated 
by the end of the study. However, procedural success is a crude 
outcome measure determined at the end of the study and may not 
reflect the final outcome for each child, whose pathway may extend 
beyond this time.
4.2 | Strengths of the study
Our study represents the largest multi-centre prospective study of 
balloon dilatation in treatment of laryngotracheal stenosis in the UK. 
Good clinician engagement with the AIR was achieved, with a high 
volume of registered users and centres thus enabling collection of 
rich data (not routinely available from administrative data).
4.3 | Comparisons with other studies
Previously published evidence on the efficacy of balloon dilatation 
in the treatment of laryngotracheal stenosis in children is limited to 
retrospective case reviews and case reports. One systematic review, 
including seven case series and 150 patients, estimated the overall 
treatment success (avoidance of tracheostomy or laryngotracheal re-
construction) as 65% (95% CI 60 to 71%) over short-term follow-up of 
7 months and mean number of 1.9 dilatation procedures per patients 
during that time.8 Another systematic review determined procedural 
success in achieving a functional airway without open surgery or tra-
cheostomy for balloon and rigid dilatation separately.7 This reported 
an overall success rate of 50% in studies using balloon dilatation alone 
(six case studies, n = 10 patients) and between 50% and 78% in stud-
ies using balloon dilatation with an adjuvant therapy including CO2 or 
KTP laser, topical or intra-lesional steroid (six studies, n = 24 patients). 
Lastly, this systematic review calculated morbidity and mortality rates 
associated with dilatation of 14% and 1%, respectively; however, this 
combines results from both balloon and rigid dilatation.
F I G U R E  3   Overall procedural success and clinical outcomes for all balloon dilatation patients (n = 59) using follow-up from the Airway 
Intervention Registry and administrative data from Hospital Episodes Statistics
Balloon dilatation +
tracheostomy
(n = 6)
Balloon dilatation 
(no tracheostomy)
(n = 1)
Success: no further 
surgical intervention
(n = 1, 100%)
Failure: further surgical 
intervention (n = 0)
Success: decannulation
(n = 4, 67%)
Failure: further surgical 
intervention (n = 2, 33%)
- 1 evidence of 
tracheostomy in place at 
end of study
- 1 failed decannulation 
and LTR
Adjunctive treatment: after 
open reconstruction surgery 
(n = 7)
Balloon dilatation +
tracheostomy
(n = 18)
Balloon dilatation 
(no tracheostomy)
(n = 34)
Success: no further 
surgical intervention
(n = 30, 88%)
Failure: further surgical 
intervention (n = 4, 12%)
- 2 tracheostomy
- 1 LTR
- 1 tracheostomy + LTR
Success: decannulation
(n = 4, 22%)
Failure: further surgical 
intervention (n = 14, 78%)
- 9 evidence of 
tracheostomy in place at 
end of study
- 3 LTR
- 1 failed decannulation
- 1 in-hospital cardiac 
arrest (revision cardiac 
surgery, tracheostomy 
temporarily removed and 
reinserted)
Primary treatment of 
stenosis 
(n = 52)
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Retrospective reviews have reported up to 33 balloon proce-
dures in a single patient,13 and a ten-year retrospective review in 
the UK found that 148/166 patients (89%) required multiple balloon 
procedures.14 In our study, 56% of patients (33/59) had multiple bal-
loon procedures to maintain the airway. Therefore, balloon dilation 
is one modality which should be considered as part of a series of 
interventions and form part of a management plan.
4.4 | Clinical applicability of the study
Short-term efficacy evidence demonstrates a significant increase 
in subglottic airway diameter, which is independent of pre-balloon 
Cotton-Myer grade, airway diameter, stenotic type and balloon 
procedure number. Some patients show a clear benefit in increased 
airway following balloon dilatation which is sustained over time; 
however due to heterogeneity in patients (ie tracheostomy status, 
prematurity, stenotic type soft/hard and congenital cause), we did 
not identify particular patient characteristics that predicted benefit. 
Additionally, our study did not have enough information to deter-
mine change in patient quality of life.
The long-term increases in airway diameter found in this study 
were not compared with the increases expected due to natural 
growth;6 however, the natural history of progression of airway steno-
sis is not well understood. It cannot be assumed that stenosis will pro-
gressively widen with the general growth of the child. In many cases, 
soft stenosis will worsen over time and result in a firmer and narrower 
stenotic segment. Therefore, demonstration of a significant and sus-
tained increase in airway diameter in this complex population over 
time does add to the evidence base for the procedures. However, one 
needs to consider the high likelihood of multiple balloon procedures 
and the requirement for adjunctive treatments to maintain the airway.
The prospective AIR database was set up to capture safety and 
efficacy evidence for balloon dilatation procedures, and by conduct-
ing pseudonymised linkage to administrative data, we have been 
able to demonstrate both short- and long-term safety and efficacy 
to support the use of balloon dilatation in the treatment of subglottic 
stenosis.
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